Abstract Background-The incidence figures for ulcerative colitis (UC) and Crohn's disease (CD) have been difficult to interpret, and geographical variations may be due to differences in classification criteria and study design. Few studies have based the incidence on prospective systematic follow up to confirm the initial diagnosis. Methods-Between 1990 and 1993, in a prospective incidence study of inflammatory bowel disease (IBD) in south eastern Norway, 527 cases of UC, 228 cases of CD, 36 cases of indeterminate colitis (IND), and 55 cases of possible IBD were identified, yielding an annual incidence of 13-6, 5 9, 0 9, and 1-4 per 105 respectively. The diagnosis and all clinical data were reviewed by two gastroenterologists independently of each other. One to two years after diagnosis, all patients were offered a clinical follow up in which the initial diagnosis was assessed. Results-Between the time of diagnosis and the follow up, 16 patients had died, four of complications related to IBD. Of the remaining 830 patients, 98% (814/830) were available for follow up, 93% (772/830) attended a clinical examination which included a colonoscopy in 77% (637/830), and the remainder had had a telephone interview, or reassessment based on hospital records, or both. Twenty seven patients were reclassified as not having IBD (3%), and 65 patients were characterised as possible IBD (8%). Of the patients initially classified as UC, 88% had their diagnosis confirmed, compared with 91% with an initial diagnosis of CD. In patients with indeterminate colitis, 33% were classified as definite UC and 17% as CD. This reclassification of patients yielded a corrected annual incidence of 12-8 for UC and 6-0 for CD. Conclusion-At follow up one to two years after the diagnosis of IBD, the initial incidence was only marginally altered. This is probably due to uniform inclusion criteria and careful diagnostic methods. The study also illustrates the importance of the reevaluation of the initial diagnosis as close to 10%, both among patients with UC and CD, were reclassified at follow up. (Gut 1997; 40: 328-332) Keywords: Crohn's disease, diagnosis assurance, epidemiology, incidence, indeterminate colitis, ulcerative colitis.
Descriptive epidemiological studies of inflammatory bowel disease (IBD) have disclosed a high annual incidence, especially in the northern hemisphere and Scandinavia.'-"1 The time trends are difficult to interpret, and the reported incidence shows considerable geographical variation. This may be due to differences in the diagnostic methods and classification criteria. Moreover, there is an inherent difference between retrospective and prospective studies.
In retrospective studies, the diagnosis is automatically re-evaluated because in most instances the clinical course has been followed up for years after the patients have been included in the study. In most prospective studies, on the other hand, there is no validation of the diagnosis as mostly the information about a patient is confined to what was current at the time of inclusion. This could well lead to the point estimate of the incidence being too high if the criteria are not stringent enough or too low if the criteria are too stringent.'-"' The classification indeterminate colitis (IND) -which was initially applied by Price in 1978 to patients in whom it was impossible to distinguish ulcerative colitis (UC) from Crohn's disease (CD) '8 19_ and the classification possible IBD also constitute a problem. In most other studies patients classified as having IND or possible IBD are not included in the initial incidence, and there are only two studies of the incidence of IBD, one of which was prospective, in which the classification IND has been used as a separate entity. [20] [21] [22] Moreover, in up to 40% of patients with a clinical picture of acute colitis usually no definite aetiology can be found; they probably have an acute reversible infection in which the organisms cannot be identified by routine culture.23 Although endoscopy with biopsy can help to distinguish infectious colitis from a first attack of IBD, there will always be some patients for whom the primary diagnosis will remain uncertain. This uncertainty can be minimised by a re-evaluation of the diagnosis over a follow up of 12 months or more, utilising all the data available for each individual patient. '6 2426 In a previously presented prospective study of the incidence of IBD between 1990 and 1993 in south eastern Norway we identified 527 cases of UC, 228 cases of CD, 36 cases of IND, and 55 cases of possible IBD, which yielded an annual incidence of 13 6 , 5.9, 0 9, and 1 4 per 10i respectively.20 21 27 Re-evaluation ofdiagnosis ofinflammatory bowel disease
The aim of the present study was to reevaluate the initial diagnosis in these patients 12 months later to assess the extent to which such a re-evaluation affects the original incidence figures.2' 27 Methods The study covered four geographically well defined areas in south eastern Norway with a total population on 1 January 1992 of 966 427 inhabitants, all of whom had uniform access to well organised healthcare services. 28 The administration and organisation of the study as a whole, with a senior gastroenterologist responsible for the clinical examination and collection of patient data in all four counties, has been described in previous publications.20 21 27 The extent and localisation of colonic disease were based on endoscopical findings and were verified by characteristic histological signs of inflammation in the same parts of the colon. 20 The basis for inclusion in the study was that the patient had had symptoms consistent with IBD for more than four weeks, excluding infections and other acute or chronic non-IBD. The diagnosis of UC was based on the presence of at least three of the following criteria: (1) a history of diarrhoea and/or blood or pus in the stools; (2) 29 The diagnostic criterion for the classification of IND was that both endoscopy and histopathology were conclusive for a diagnosis of IBD but divergent or inconclusive for a diagnosis of definite UC or CD. For example, in one and the same patient, features typical of one disease might be evident at endoscopy while histopathology showed signs of the other or the endoscopical distribution indicated one disease whereas the appearance of the macroscopic or microscopical changes were more typical of the other. Thus characteristics of both diseases could be present either at endoscopy, histopathology, or both. If the patient had symptoms and signs of IBD at the initial stage of the investigation but did not fulfil the criteria for definite IBD, if the quality of the diagnostic examination was not satisfactory, or the findings were uncertain, the classification of possible IBD was used.
All initial slides were reviewed by the same pathologist at follow up. Moreover, cases classified as IND and possible IBD were discussed and reviewed by the diagnosing gastroenterologists and one of the gastroenterologists at the university hospital.
Patients were followed up for a period of at least 12 months and were then asked to return to the local hospital for a re-examination, if possible by the doctor who had performed the initial examination. The main purpose of this was to review the primary diagnosis by an interview, a clinical examination, laboratory tests, and if necessary and if agreed to by the patient, colonoscopy with biopsies and small bowel enema. The time lag from the first examination and this follow up was on average 14 months (interquartile range [12] [13] [14] [15] [16] [17] [18] . In some cases the follow up examination had to be replaced by a telephone interview, sometimes supplemented by hospital notes. For patients who could not be reached by telephone, hospital records were used.
As a further test of the validity of our classification, we broke down the figures for each diagnosis according to the disease distribution. (Table I) . Of the 27 cases classified as non-IBD, 56% (15/27) were initially classified as IND or possible IBD, -that is, of the UC and CD cases only 2% and 1% respectively were later reclassified as having non-IBD. The initial classification shows that the main reason why these 27 patients were reclassified as non-IBD was an uncertain diagnosis from the beginning. Furthermore, they had no relapses or disease activity during the follow up period and at follow up there were no endoscopical findings, histological signs of inflammation, or pathological findings on small bowel radiography. 14 16 17 Despite meticulous diagnostic efforts, in as many as 9% of the patients (n=75) with IND or possible IBD definitive UC or CD could not be confirmed after the follow up period, which raises problems in the further diagnostic characterisation of these patients. However, the numbers are so low they would have little influence on the incidence.
There was a small but not significant reduction in the incidence of UC, whereas the incidence of CD remained more or less unaltered, which means that the overall incidence of IBD is still consistent with the high incidence reported in other studies in Norway and Scandinavia in the 1970s and 1980s.2 7 14 There were some differences in the mean annual incidence of UC and CD between the four counties at the time of diagnosis.2' 27 The re-evaluation of the diagnosis had no effect on these differences in incidence, as there were no differences in the proportion of patients excluded as not having IBD. The high annual incidence of UC and CD in this study, and the higher incidence in mixed ruralurban than in urban areas, therefore seem to be real.
Most of the cases of UC reclassified as CD had extensive colitis initially, but in the other patients with UC no difference was found between subgroups with respect to distribution and reclassification of disease. As expected, nearly all the patients initially classified as CD who received a new diagnosis had colonic disease only. One third of these patients were rediagnosed as having UC. There was a very high diagnostic accuracy initially compared with follow up diagnosis in patients with small bowel disease (Table II) .
In a small group of patients the distinction between UG and CD may be difficult and must, at least temporarily, be left unresolved. The term "indeterminate colitis" ought thus to be used until more definitive information is collected, and it should be regarded as a provisional, descriptive term rather than as a specific diagnostic entity.22
The importance of an accurate diagnosis must be emphasised if we are to discover more about these diseases and their pathogenic factors. Furthermore, a precise diagnosis is necessary if clinicians and researchers are to be able to communicate with each other internationally.
In conclusion, this prospective study, which was designed to ensure a high validity of the diagnosis of UC and CD by means of a reevaluation after one year resulted in only marginal alterations in the initial incidence for the two diseases. This is probably due to the uniform, stringent inclusion criteria and to the diagnostic methods used. Despite the high correlation between the initial diagnosis and the diagnosis at follow up, the study illustrates the importance for the individual patients of re-evaluating the initial diagnosis, as close to 10% of patients with UC and with CD were reclassified at the time of follow up. 
